NovMetaPharma Co., Ltd. (XKON:229500)
South Korea · Delayed Price · Currency is KRW 5,290.00
+660.00 (14.25%)
At close: Sep 23, 2026
NovMetaPharma Market Cap
NovMetaPharma has a market cap or net worth of 67.93 billion as of September 25, 2026. Its market cap has decreased by -64.34% in one year.
Market Cap
67.93B
Enterprise Value
n/a
Revenue
1.30B
Ranking
n/a
PE Ratio
44.08
Stock Price
5,290.00
ChartMarket Cap Chart
Since April 5, 2017, NovMetaPharma's market cap has decreased from 74.59B to 67.93B, a decrease of -8.93%. That is a compound annual growth rate of -0.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 67.93B | -58.50% |
| Dec 30, 2025 | 163.69B | 187.16% |
| Dec 30, 2024 | 57.00B | -46.33% |
| Dec 29, 2022 | 106.21B | -45.89% |
| Dec 30, 2021 | 196.29B | -9.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EyeGene | 84.30B |
| BIO-FD&C | 79.74B |
| Naturalendo Tech | 74.67B |
| CTCBIO | 71.85B |
| IMGT Co.,Ltd. | 69.86B |
| SunBio,Inc. | 68.77B |
| PanGen Biotech | 64.94B |
| ABION | 60.91B |